Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
7.72%
operating margin TTM
20.74%
revenue TTM
554.66 Million
revenue per share TTM
17.55$
valuation ratios | |
|---|---|
| pe ratio | 26.41 |
| peg ratio | 0.47 |
| price to book ratio | 5.62 |
| price to sales ratio | 2.04 |
| enterprise value multiple | 2.65 |
| price fair value | 5.62 |
profitability ratios | |
|---|---|
| gross profit margin | 57.22% |
| operating profit margin | 20.74% |
| pretax profit margin | 10.68% |
| net profit margin | 7.72% |
| return on assets | 3.64% |
| return on equity | 24.09% |
| return on capital employed | 13.6% |
liquidity ratios | |
|---|---|
| current ratio | 1.36 |
| quick ratio | 1.27 |
| cash ratio | 0.33 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 42.88 |
| operating cycle | 155.67 |
| days of payables outstanding | 8.62 |
| cash conversion cycle | 147.06 |
| receivables turnover | 3.24 |
| payables turnover | 42.36 |
| inventory turnover | 8.51 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.51 |
| debt equity ratio | 2.96 |
| long term debt to capitalization | 0.73 |
| total debt to capitalization | 0.75 |
| interest coverage | 3.73 |
| cash flow to debt ratio | 0.36 |
cash flow ratios | |
|---|---|
| free cash flow per share | 9.16 |
| cash per share | 9.05 |
| operating cash flow per share | 9.21 |
| free cash flow operating cash flow ratio | 0.99 |
| cash flow coverage ratios | 0.36 |
| short term coverage ratios | 4.41 |
| capital expenditure coverage ratio | 179.47 |
Frequently Asked Questions
When was the last time Collegium Pharmaceutical, Inc. (NASDAQ:COLL) reported earnings?
Collegium Pharmaceutical, Inc. (COLL) published its most recent earnings results on 06-11-2025.
What is Collegium Pharmaceutical, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Collegium Pharmaceutical, Inc. (NASDAQ:COLL)'s trailing twelve months ROE is 24.09%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Collegium Pharmaceutical, Inc. (COLL) currently has a ROA of 3.64%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did COLL's net profit margin stand at?
COLL reported a profit margin of 7.72% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is COLL's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.36 in the most recent quarter. The quick ratio stood at 1.27, with a Debt/Eq ratio of 2.96.